United States · Markets & Finance · Investing.com
Mineralys Therapeutics stock hits 52-week low at 20.4 USD
Mineralys Therapeutics Inc stock reached a 52-week low, closing at 20.4 USD, down 57% from its 52-week high of $47.65. Over the past year, the company’s stock has experienced a ...
Read the full article on Investing.com Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)




